Get started
Author

Yoriko Harazaki

ORCID: 0000-0003-1299-616X
Observed ORCID: 0000-0003-1299-616X
OpenAlex ID: A5085648676
ctDNA improves prognostic prediction for patients with relapsed/refractory MM receiving ixazomib, lenalidomide, and dexamethasone
2024 · Yasunori Kogure, Hiroshi Handa, et al. · Blood · 21
PDF
Myeloid Sarcoma of the Paranasal Sinuses in a Patient with Acute Myeloid Leukemia
2018 · Jun Suzuki, Yoriko Harazaki, et al. · The Tohoku Journal of Experimental Medicine · 17
PDF
Outcomes of adult patients with early T-cell precursor (ETP) acute lymphoblastic leukemia/lymphoma (ALL) and non-ETP T-ALL
2023 · Yasushi Onishi, Eijiro Furukawa, et al. · International Journal of Hematology · 9
A prospective, multicenter, observational study of ixazomib plus lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma in Japan
2023 · Yuichi Horigome, Masaki Iino, et al. · Annals of Hematology · 5
PDF
Outcomes of poor peripheral blood stem cell mobilizers with multiple myeloma at the first mobilization: A multicenter retrospective study in Japan
2022 · Yurie Miyamoto‐Nagai, Naoya Mimura, et al. · eJHaem · 4
Changing trends in the risk factors for second primary malignancies after autologous stem cell transplantation for multiple myeloma before and after the introduction of proteasome inhibitors and immunomodulatory drugs
2023 · Hiroyuki Takamatsu, Tomohiro Matsuda, et al. · Haematologica · 3
PDF
The Outcomes of Single-unit Unrelated Umbilical Cord Blood Transplantation for Adult Acute Myeloid Leukemia with RUNX1::RUNX1T1 in Multicenter Retrospective analysis
2026 · Kazuki Sakurai, Hisayuki Yokoyama, et al. · Transplantation Proceedings
P929: Circulating Tumor Dna Assessment Improves Prognostic Prediction in Relapsed/refractory Multiple Myeloma Receiving Ixazomib, Lenalidomide, and Dexamethasone
2023 · Yasunori Kogure, Hiroshi Handa, et al. · HemaSphere
Rapid progression of left ventricular hypertrophy caused by leukaemic infiltration of myocardium
2023 · Azusa Nagano, Hiroshi Kato, et al. · European Heart Journal - Cardiovascular Imaging
PDF
P-248: A prospective, multicenter, observational study of ixazomib plus lenalidomide-dexamethasone in 295 Japanese patients with relapsed/refractory multiple myeloma
2022 · Masaki Iino, Yuichi Horigome, et al. · Clinical Lymphoma Myeloma & Leukemia
A retrospective analysis of daratumumab for RRMM in our institute
2019 · Yoriko Harazaki · The Japanese Society of Hematology
A New Prognostic Index for Waldenström Macroglobulinemia Based on a Multicenter Retrospective Study of the Japanese Society of Myeloma
2018 · Akio Saito, Atsushi Isoda, et al. · Blood
Works count: 12
Citation count: 59
H-index: 4
I10-index: 2
Year
Topic
Type